Anew Medical, Performance
| WENADelisted Stock | 0.73 0.05 6.41% |
The firm shows a Beta (market volatility) of 3.45, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Anew Medical, will likely underperform. At this point, Anew Medical, has a negative expected return of -0.95%. Please make sure to confirm Anew Medical,'s treynor ratio, accumulation distribution, price action indicator, as well as the relationship between the potential upside and day median price , to decide if Anew Medical, performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Anew Medical, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Begin Period Cash Flow | 341 K |
Anew |
Anew Medical, Relative Risk vs. Return Landscape
If you would invest 81.00 in Anew Medical, on September 5, 2024 and sell it today you would lose (8.00) from holding Anew Medical, or give up 9.88% of portfolio value over 90 days. Anew Medical, is currently does not generate positive expected returns and assumes 6.8497% risk (volatility on return distribution) over the 90 days horizon. In different words, 60% of stocks are less volatile than Anew, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Anew Medical, Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Anew Medical,'s investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Anew Medical,, and traders can use it to determine the average amount a Anew Medical,'s price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1385
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | WENA |
Estimated Market Risk
| 6.85 actual daily | 60 60% of assets are less volatile |
Expected Return
| -0.95 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Anew Medical, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Anew Medical, by adding Anew Medical, to a well-diversified portfolio.
Anew Medical, Fundamentals Growth
Anew Stock prices reflect investors' perceptions of the future prospects and financial health of Anew Medical,, and Anew Medical, fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Anew Stock performance.
| Return On Asset | -0.24 | |||
| Current Valuation | 18.58 M | |||
| Shares Outstanding | 21.26 M | |||
| Price To Book | 43.36 X | |||
| EBITDA | (1.3 M) | |||
| Total Debt | 1.6 M | |||
| Book Value Per Share | (0.1) X | |||
| Cash Flow From Operations | (1.26 M) | |||
| Total Asset | 19.46 M | |||
| Retained Earnings | (7.35 M) | |||
About Anew Medical, Performance
By analyzing Anew Medical,'s fundamental ratios, stakeholders can gain valuable insights into Anew Medical,'s financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Anew Medical, has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Anew Medical, has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Anew Medical, performance evaluation
Checking the ongoing alerts about Anew Medical, for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Anew Medical, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Anew Medical, is now traded under the symbol KLTO. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Anew Medical, is not yet fully synchronised with the market data | |
| Anew Medical, generated a negative expected return over the last 90 days | |
| Anew Medical, has high historical volatility and very poor performance | |
| Anew Medical, has some characteristics of a very speculative penny stock | |
| Anew Medical, has a very high chance of going through financial distress in the upcoming years | |
| Anew Medical, was previously known as Redwoods Acquisition Corp and was traded on NASDAQ Exchange under the symbol RWOD. | |
| Anew Medical, generates negative cash flow from operations | |
| About 80.0% of the company outstanding shares are owned by insiders |
- Analyzing Anew Medical,'s financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Anew Medical,'s stock is overvalued or undervalued compared to its peers.
- Examining Anew Medical,'s industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Anew Medical,'s management team can have a significant impact on its success or failure. Reviewing the track record and experience of Anew Medical,'s management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Anew Medical,'s stock. These opinions can provide insight into Anew Medical,'s potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Anew Stock
If you are still planning to invest in Anew Medical, check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anew Medical,'s history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |